The frequencies of different inborn errors of metabolism in adult metabolic centres: Report from the SSIEM adult metabolic physicians group

JIMD Reports

Volumn 27, Issue , 2016, Pages 85-91

  Sirrs, S ^a   Hollak, C ^b   Merkel, M ^c   Sechi, A ^d   Glamuzina, E ^e   Janssen, M C ^f   Lachmann, R ^g   Langendonk, J ^h   Scarpelli, M ⁱ   Ben Omran, T ^j   Mochel, F ^k   Tchan, M C ^l   Besson, G ^m   Bienvenu, B ^m   Corne, C ^m   Douillard, C ^m   Garnotel, R ^m   Goizet, C ^m   Jaussaud, R ^m   Kaminsky, P ^m   Kaphan, E ^m   Laforet P ^k   Lavigne, C ^m   Leguy Seguin, V ^m   Maillot, F ^m   Mazodier, K ^m   Nadjar, Y ^k   Noel, E ^m   Read, M H ^m   Servais, A ⁿ   Thauvin, C ^m   Tourbah, A ^m   more..

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c DEPARTMENT OF CARDIOLOGY   (Germany)

^d SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^e STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ G B ROSSI UNIVERSITY HOSPITAL   (Italy)

^j Qatar Medical Genetics Center   (Qatar)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l WESTMEAD HOSPITAL   (Australia)

^m Pitié Salpêtrière hospital ^*  (France)

ⁿ HÔPITAL NECKER ENFANTS MALADES   (France)

more..

Author keywords

Fabry disease; Gauche disease; Glycogen storage disease; Mitochondrial disease; Newborn screening

Indexed keywords

EID: 84992686518     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2015_435     Document Type: Chapter

References (17)

1. Carpenter K, Wiley V, Sim KG, Heath D, Wilcken B (2001) Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275,000 babies. Arch Dis Child Fetal Neonatal Ed 85(2):F105–F109
2. Desnick RJ, Ioannou YA, Eng CM (2007) Alpha galactosidase A deficiency: Fabry disease. Online Metab Mol Bases Inherited Dis 3733–3774
3. El-Hattab AW, Li FY, Shen J et al (2010) Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet Med 12 (1):19–24
4. Garman SC (2007) Structure-function relationships in alpha-galactosi-dase A. Acta Paediatr Suppl 96(455):6–16
5. Gaspar P, Herrera J, Rodrigues D et al (2010) Frequency of Fabry disease in male and female haemodialysis patients in Spain. BMC Med Genet 11:19
6. Lang TF (2009) Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD). J Inherit Metab Dis 32 (6):675–683
7. Lee NC, Tang NL, Chien YH et al (2010) Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab 100(1):46–50
8. Palecek T, Honzikova J, Poupetova H et al (2014) Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS). J Inherit Metab Dis 37(3):455–460
9. Rolfs A, Bottcher T, Zschiesche M et al (2005) Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366(9499):1794–1796
10. Sander S, Janzen N, Janetzky B et al (2001) Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany). Eur J Pediatr 160(5):318–319
11. Saudubray JM, Walter JH, van der Berghe G (eds) (2012) Inborn metabolic diseases: diagnosis and treatment. Springer, Berlin, Heidelberg, New York.
12. Schaefer AM, McFarland R, Blakely EL et al (2008) Prevalence of mitochondrial DNA disease in adults. Ann Neurol 63(1):35–39
13. Spada M, Pagliardini S, Yasuda M et al (2006) High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 79(1):31–40
14. van der Tol L, Smid BE, Poorthuis BJ et al (2014) A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance. J Med Genet 51(1):1–9
15. Vijay S, Patterson A, Olpin S et al (2006) Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants. J Inherit Metab Dis 29 (5):627–630
16. Wilcken B (2010) Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis 33(5):501–506
17. Wilcken B, Haas M, Joy P et al (2007) Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet 369(9555):37–42